Alerts will be sent to your verified email
Verify Email
GANGAPHARM
|
Ganga Pharma.
|
Hind Bio Science
|
Cian Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.2 % | -26.49 % | -2.49 % |
|
5yr Avg Net Profit Margin
|
2.35 % | -41.21 % | -2.06 % |
|
Price to Book
|
0.0 | 8.84 | 0.0 |
|
P/E
|
110.65 | 280.19 | 32.93 |
|
5yr Avg Cash Conversion Cycle
|
183.46 Days | 136.38 Days | -692.15 Days |
|
5yr Average Interest Coverage Ratio
|
1.42 | -43.62 | 0.8 |
|
5yr Avg ROCE
|
4.7 % | -14.23 % | 5.59 % |
|
5yr Avg Operating Profit Margin
|
3.58 % | -39.73 % | 14.07 % |
|
5 yr average Debt to Equity
|
0.3 | 2.36 | 1.12 |
|
5yr CAGR Net Profit
|
-23.43 % | -5.59 % | n/a |
|
5yr Average Return on Assets
|
0.85 % | -8.5 % | -0.86 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.91 % | 12.19 % | 27.1 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 34.48 % |
|
Change in Promoter Holding (3 Yrs)
|
-15.8 % | 0.0 | -43.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ganga Pharma.
|
Hind Bio Science
|
Cian Healthcare
|
|---|